Výsledky vyhledávání - "Amaya Arrondo-Velasco"

Akademický článek

Adherence to treatment with adalimumab, golimumab and ustekinumab in patients with inflammatory bowel disease

Autor: María Calvo-Arbeloa, Ana María Insausti-Serrano, Amaya Arrondo-Velasco, María Teresa Sarobe-Carricas

Publikováno v: Farmacia Hospitalaria, Vol 44, Iss 2, Pp 62-67 (2020)

Objective: Inflammatory bowel disease comprises a group of chronic relapsing inflammatory disorders affecting the bowel. In the last decade, the advent of biological drugs brought about a drastic change in the treatment of the disease. Adalimumab, go

Externí odkaz: https://doaj.org/article/1de4ddd4e670422a9cd580312e4e6bcb

Zobrazit plný text záznamu

Implementation of pharmaceutical care through Telepharmacy: A guide for professionals and patients

Autor: Ramón, Morillo-Verdugo, Roberto, Collado-Borell, Amaya, Arrondo-Velasco, Marcelo, Domínguez-Cantero, Aurora, Fernández-Polo, Elena, González-Corominas, Esperanza, Gutiérrez, Aránzazu, Linares-Alarcón, María de Los Ángeles, Parro-Martín, Miguel Ángel, Rodríguez-Cabezas, Mar, Gomis-Pastor

Publikováno v: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 46(7)

To provide a practical guide for the implementation and use of Pharmaceutical Care through Telepharmacy by healthcare professionals and patients in its different scopes of application. To establish a definition of Telepharmacy and describe the techno

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0cfe94ea2a5a6d250dffaf897c8dfa0e
https://pubmed.ncbi.nlm.nih.gov/36520566

Zobrazit plný text záznamu

Improvement in RAID questionnaire results in patients with rheumatoid arthritis treated with advanced therapies

Autor: Andrea Rodríguez Esquíroz, Amaya Arrondo Velasco, Amaia Egüés Lugea, Maite Sarobe Carricas

Publikováno v: European journal of hospital pharmacy : science and practice.

To analyse the changes in patient-reported outcomes after starting advanced antirheumatic treatment.The study included all patients who started self-administered biological or targeted synthetic treatments for rheumatoid arthritis between February an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b1f77dc1b72652e69aa2508c5ab21e2
https://pubmed.ncbi.nlm.nih.gov/35228268

Zobrazit plný text záznamu